NCT01186133 Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
| NCT ID | NCT01186133 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seung-Jung Park |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2009-01 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2009-01 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Eligibility Criteria
Inclusion Criteria: * coronary disease amenable to percutaneous coronary intervention (PCI) * no clinical and lesion limitations Exclusion Criteria: * patients with a mixture of several DES * terminal illness with life expectancy less than 1 year * patients with cardiogenic shock
Contact & Investigator
Seung-Jung Park, MD
✉ sjpark@amc.seoul.krSeung-Jung Park, MD
STUDY CHAIR
Asan Medical Center
Frequently Asked Questions
Who can join the NCT01186133 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01186133 currently recruiting?
Yes, NCT01186133 is actively recruiting participants. Contact the research team at sjpark@amc.seoul.kr for enrollment information.
Where is the NCT01186133 trial being conducted?
This trial is being conducted at Multiple Locations, South Korea.
Who is sponsoring the NCT01186133 clinical trial?
NCT01186133 is sponsored by Seung-Jung Park. The principal investigator is Seung-Jung Park, MD at Asan Medical Center. The trial plans to enroll 50,000 participants.